Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis
Abstract Background A quantitative measurement of serum proteome biomarkers that would associate with disease progression endpoints can provide risk stratification for persons with multiple sclerosis (PwMS) and supplement the clinical decision‐making process. Materials and Methods In total, 202 PwMS...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Jezik: | English |
Izdano: |
Wiley
2024-03-01
|
Serija: | Annals of Clinical and Translational Neurology |
Online dostop: | https://doi.org/10.1002/acn3.51996 |